Open AccessSerum Antibody Responses against Carbapenem-Resistant Klebsiella pneumoniae in Infected Patients
Author(s) -
Kasturi Banerjee,
Michael P. Motley,
Elizabeth Diago-Navarro,
Bettina C. Fries
Publication year - 2021
Publication title -
msphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.749
H-Index - 39
ISSN - 2379-5042
DOI - 10.1128/msphere.01335-20
Subject(s) - klebsiella pneumoniae , antibody , microbiology and biotechnology , phagocytosis , serotype , titer , immunoglobulin g , medicine , immunology , biology , escherichia coli , biochemistry , gene
Carbapenem-resistantKlebsiella pneumoniae is a rapidly emerging public health threat that can cause fatal infections in up to 50% of affected patients. Due to its resistance to nearly all antimicrobials, development of alternate therapies like antibodies and vaccines is urgently needed.